Published in Microb Pathog on November 01, 2002
The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes. Nat Rev Microbiol (2010) 2.25
Haemophilus influenzae: genetic variability and natural selection to identify virulence factors. Infect Immun (2004) 1.38
A widely conserved gene cluster required for lactate utilization in Bacillus subtilis and its involvement in biofilm formation. J Bacteriol (2009) 1.25
Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection. PLoS Pathog (2011) 1.19
Initial proteome analysis of model microorganism Haemophilus influenzae strain Rd KW20. J Bacteriol (2003) 1.13
Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants. Infect Immun (2003) 1.05
The periplasmic disulfide oxidoreductase DsbA contributes to Haemophilus influenzae pathogenesis. Infect Immun (2008) 1.02
Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae. Infect Immun (2006) 0.99
NAD+ utilization in Pasteurellaceae: simplification of a complex pathway. J Bacteriol (2006) 0.99
Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses. BMC Microbiol (2010) 0.94
Effect of host lactate on gonococci and meningococci: new concepts on the role of metabolites in pathogenicity. Infect Immun (2007) 0.90
Functional annotation of conserved hypothetical proteins from Haemophilus influenzae Rd KW20. PLoS One (2013) 0.88
Nicotinamide ribosyl uptake mutants in Haemophilus influenzae. Infect Immun (2003) 0.86
The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing. J Biol Chem (2010) 0.86
Genome-scale approaches to identify genes essential for Haemophilus influenzae pathogenesis. Front Cell Infect Microbiol (2012) 0.82
Coupling of NAD+ biosynthesis and nicotinamide ribosyl transport: characterization of NadR ribonucleotide kinase mutants of Haemophilus influenzae. J Bacteriol (2005) 0.82
Characterization of lactate utilization and its implication on the physiology of Haemophilus influenzae. Int J Med Microbiol (2014) 0.79
Bioinformatics annotation of the hypothetical proteins found by omics techniques can help to disclose additional virulence factors. Curr Microbiol (2009) 0.78
Identification of the genes that contribute to lactate utilization in Helicobacter pylori. PLoS One (2014) 0.78
LUD, a new protein domain associated with lactate utilization. BMC Bioinformatics (2013) 0.76
A role for lactate dehydrogenases in the survival of Neisseria gonorrhoeae in human polymorphonuclear leukocytes and cervical epithelial cells. J Infect Dis (2014) 0.75
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
The gal locus from Haemophilus influenzae: cloning, sequencing and the use of gal mutants to study lipopolysaccharide. Mol Microbiol (1992) 9.22
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet (1989) 4.35
PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol (1994) 4.08
Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06
Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet (1997) 3.69
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell (1989) 3.60
Do general practitioners know when living wills are legal? J R Coll Physicians Lond (1998) 3.39
DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc Natl Acad Sci U S A (1996) 3.38
The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis (1981) 3.24
Clonal population structure of encapsulated Haemophilus influenzae. Infect Immun (1988) 3.03
Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence. J Clin Invest (1984) 2.94
Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol (1997) 2.91
Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates. Lancet (1993) 2.88
Genetics of spontaneous, high-frequency loss of b capsule expression in Haemophilus influenzae. Infect Immun (1985) 2.84
Simple sequence repeats in the Helicobacter pylori genome. Mol Microbiol (1998) 2.75
Functional genomics of Neisseria meningitidis pathogenesis. Nat Med (2000) 2.73
Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1988) 2.68
The bex locus in encapsulated Haemophilus influenzae: a chromosomal region involved in capsule polysaccharide export. Mol Microbiol (1990) 2.49
Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell (1988) 2.49
Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol (2000) 2.44
Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol (1990) 2.42
Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev (1997) 2.42
Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet (1981) 2.41
Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun (1977) 2.39
The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol Microbiol (1991) 2.36
The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis (1995) 2.31
Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol (1993) 2.26
Detection and quantitation of bacteremia in childhood. J Pediatr (1977) 2.21
Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci (1993) 2.18
Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol Microbiol (1995) 2.18
Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol (2002) 2.18
The length of a tetranucleotide repeat tract in Haemophilus influenzae determines the phase variation rate of a gene with homology to type III DNA methyltransferases. Mol Microbiol (2000) 2.13
Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J Infect Dis (1977) 2.09
Characterization of repetitive sequences controlling phase variation of Haemophilus influenzae lipopolysaccharide. J Bacteriol (1990) 2.08
Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. JAMA (2000) 2.07
Analyzing derived stimulus relations requires more than the concept of stimulus class. J Exp Anal Behav (1997) 2.06
Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats. J Infect Dis (1983) 2.06
The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J Clin Invest (2001) 2.04
The Haemophilus influenzae capsulation gene cluster: a compound transposon. Mol Microbiol (1991) 2.03
Multivalent endosome targeting by homodimeric EEA1. Mol Cell (2001) 2.03
The role of a repetitive DNA motif (5'-CAAT-3') in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope alpha Gal(1-4)beta Gal. Mol Microbiol (1993) 1.98
Capsulation in distantly related strains of Haemophilus influenzae type b: genetic drift and gene transfer at the capsulation locus. J Bacteriol (1990) 1.98
Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae. J Bacteriol (1989) 1.96
Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol Microbiol (1994) 1.96
Haemophilus influenzae type b disease in the Oxford region. Arch Dis Child (1989) 1.95
Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol Microbiol (1995) 1.93
Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc Natl Acad Sci U S A (1978) 1.88
Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol Microbiol (1999) 1.88
Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA (2000) 1.83
Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Mol Microbiol (1996) 1.79
Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr (1986) 1.79
IgA1 proteases of Haemophilus influenzae: cloning and characterization in Escherichia coli K-12. Proc Natl Acad Sci U S A (1983) 1.77
Genes involved in Haemophilus influenzae type b capsule expression are part of an 18-kilobase tandem duplication. Proc Natl Acad Sci U S A (1986) 1.76
Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. Microb Pathog (1986) 1.75
Control of short leftward transcripts from the immunity and ori regions in induced coliphage lambda. Mol Gen Genet (1973) 1.74
Absence in Helicobacter pylori of an uptake sequence for enhancing uptake of homospecific DNA during transformation. Microbiology (1999) 1.73
Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol Microbiol (1992) 1.72
Identification and characterization of in vivo attenuated mutants of Brucella melitensis. Mol Microbiol (2000) 1.71
Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b. J Bacteriol (1988) 1.67
Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis (2000) 1.65
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology (2007) 1.63
Indirect enzyme-linked immunosorbent assay for the quantitation of the type-specific antigen of Haemophilus influenzae b: a preliminary report. J Pediatr (1980) 1.59
Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16). Cell (1994) 1.57
Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Haemophilus influenzae. Infect Immun (1989) 1.56
Alteration of the cell wall of Haemophilus influenzae type b by transformation with cloned DNA: association with attenuated virulence. J Infect Dis (1985) 1.56
Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region. Lancet (1992) 1.55
Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation. Mol Microbiol (2003) 1.54
The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology (1999) 1.53
Region II of the Haemophilus influenzae type be capsulation locus is involved in serotype-specific polysaccharide synthesis. Mol Microbiol (1995) 1.52
Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial cells; the role of integrins in apical interactions. Mol Microbiol (1994) 1.51
Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing. Lancet (2000) 1.50
Compartmentalized and binary behavior of terminal dendrites in hippocampal pyramidal neurons. Science (2001) 1.49
Managed care in the Twin Cities: what can we learn? Health Aff (Millwood) (1995) 1.49
Microbial genetics. The tinkerer's evolving tool-box. Nature (1997) 1.48
Activation of the alternative complement pathway by Haemophilus influenzae type B. Infect Immun (1977) 1.46
Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae. Infect Immun (1990) 1.45
Haemophilus influenzae disease in the White Mountain Apaches: molecular epidemiology of a high risk population. Pediatr Infect Dis (1985) 1.45
Conservative management of an echovirus 11 outbreak in a neonatal unit. Lancet (1989) 1.45
The carrier state: Haemophilus influenzae. J Antimicrob Chemother (1986) 1.44
Limited genetic diversity of Haemophilus influenzae (type b). Microb Pathog (1987) 1.44